DKK1 and diabetic kidney disease: Hung, P.-H., et al. (2022). The histone demethylase inhibitor GSK-J4 is a therapeutic target for the kidney fibrosis of diabetic kidney disease via DKK1 modulation. International Journal of Molecular Sciences, 23 (16), 940,907. https://doi.org/10.3390/ijms23169407